SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-22-000097
Filing Date
2022-06-07
Accepted
2022-06-07 16:33:19
Documents
2
Period of Report
2022-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165463398025988.html 4  
1 FORM 4 wf-form4_165463398025988.xml 4 3207
2 MCVICAR POWER OF ATTORNEY mcvicarpowerofattorney.htm EX-24 3287
  Complete submission text file 0001615219-22-000097.txt   8018
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOTEK PHARMACEUTICALS CORPORATION 131 HARTWELL AVENUE, SUITE 105 LEXINGTON MA 02421
Business Address
McVicar William K. (Reporting) CIK: 0001634368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 221001565